The PE Ratio as of September 2024 (TTM) for Purple Biotech Ltd. (PPBT) is -0.54

According to Purple Biotech Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -0.54. This represents a change of -97.59% compared to the average of -22.39 of the last 4 quarters.

Purple Biotech Ltd. (PPBT) Historical PE Ratio (quarterly & annually)

How has PPBT PE Ratio performed in the past?

The mean historical PE Ratio of Purple Biotech Ltd. over the last ten years is -545.73. The current -0.54 PE Ratio has changed -90.10% with respect to the historical average. Over the past ten years (40 quarters), PPBT's PE Ratio was at its highest in in the December 2017 quarter at 1.37K. The PE Ratio was at its lowest in in the September 2018 quarter at -8071.69.

Purple Biotech Ltd. (PPBT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Purple Biotech Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Purple Biotech Ltd. (PPBT) Average PE Ratio

How has PPBT PE Ratio performed in the past?

The current PE Ratio of Purple Biotech Ltd. (PPBT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Purple Biotech Ltd. (PPBT) PE Ratio vs. Peers

How is PPBT’s PE Ratio compared to its peers?

Purple Biotech Ltd.’s PE Ratio is greater than Pluri Inc. (-1.67), greater than BioLineRx Ltd. (-1.67), less than Aridis Pharmaceuticals, Inc. (0.01), greater than Enlivex Therapeutics Ltd. (-1.37), greater than Anebulo Pharmaceuticals, Inc. (-5.77), greater than PMV Pharmaceuticals, Inc. (-1.62), greater than Miromatrix Medical Inc. (-3.41), greater than ZIVO Bioscience, Inc. (-3.13), less than Bionomics Limited (-0.19), less than Bio-Path Holdings, Inc. (-0.14), less than Endonovo Therapeutics, Inc. (-0.15), greater than Cingulate Inc. (-1.58), greater than Soleno Therapeutics, Inc. (-31.61), less than Cingulate Inc. (0), greater than SAB Biotherapeutics, Inc. (-1.58), greater than Cadrenal Therapeutics, Inc. Common Stock (-0.60), greater than Monopar Therapeutics Inc. (-2.07), greater than null (-2.21),

Build a custom stock screener for Purple Biotech Ltd. (PPBT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Purple Biotech Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Purple Biotech Ltd. (PPBT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Purple Biotech Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.